What Is 7-OH (7-Hydroxymitragynine)? Chemistry and Legal Status
Status as of 21 October 2026: 7-OH (7-hydroxymitragynine) is not yet a federally scheduled substance, but DEA has published a notice of intent to place 7-OH and mitragynine pseudoindoxyl (MP) in Schedule I above a defined threshold, through an order that can publish on or after 13 November 2026 (91 FR 65370). FDA says 7-OH is not lawful in dietary supplements, cannot be lawfully added to conventional foods and is not in any approved drug (FDA). The related compounds MP, MGM-15 and MGM-16 have been in Schedule I since 26 August 2026. At state level, the same DEA notice lists ten states that prohibit 7-OH, and California's health department says selling it for consumption is unlawful (CDPH).
This page explains what 7-OH is in plain terms: its chemistry, where it occurs in nature, how it relates to kratom, mitragynine, MP and MGM-15, and where it stands under federal and state law. It is reference material, dated and sourced. It does not describe products, effects or amounts to use.
What 7-OH is
7-OH is short for 7-hydroxymitragynine. FDA lists other names used for it, including 7-OH-mitragynine, 7-OHMG and 7-HMG (FDA). DEA describes it as a psychoactive indole alkaloid found in Mitragyna speciosa, the kratom tree, which is native to Southeast Asia (91 FR 65370).
An alkaloid is a nitrogen-containing compound made by a plant. Kratom contains many of them. NIDA names mitragynine and 7-OH as the two most studied, and says both activate mu-opioid receptors (NIDA). FDA's position is that 7-OH is an opioid, and its Commissioner has said it "can be more potent than morphine" (FDA, 29 July 2025).
The chemistry in plain terms
PubChem gives 7-OH the formula C23H30N2O5 and mitragynine C23H30N2O4 (PubChem, 7-hydroxymitragynine; PubChem, mitragynine). The two molecules share the same skeleton. 7-OH carries one extra oxygen, as a hydroxyl (OH) group at the 7 position, which is where the name comes from.
That small change matters to regulators. DEA notes that 7-OH can be made from mitragynine "through a one-step chemical reaction," that the body also produces it as an oxidized metabolite of mitragynine, and that synthetic and naturally occurring 7-OH have identical chemical structures (91 FR 65370). This page does not describe how 7-OH is extracted or made.
Trace natural 7-OH versus concentrated and semi-synthetic 7-OH
FDA says 7-OH "occurs naturally in trace amounts in kratom," and that its enforcement focuses on concentrated products and products with 7-OH added or at enhanced levels (FDA). DEA says that in the natural plant, 7-OH makes up less than two percent of the total alkaloid content or occurs in trace amounts. It also says commercial extracts and synthetic formulations contain a much higher concentration than botanical kratom (91 FR 65370).
Does all kratom contain 7-OH?
Not necessarily, and the amount varies. Federal agencies describe trace amounts in botanical kratom, but DEA's own wording is hedged: 7-OH and MP "have supposedly been found in trace amounts in some botanical kratom products" (91 FR 65370). A study abstract hosted by NIDA reported that 7-OH was not found in freshly collected leaves and described it as a post-harvest, oxidative derivative (NIDA abstract, Karunakaran and Kasinather).
The only way to know what a given sample contains is laboratory testing. Our guide to reading a kratom alkaloid lab report explains how alkaloid results are reported.
How 7-OH differs from kratom leaf
Kratom is the plant: NCCIH describes Mitragyna speciosa as a tree in the coffee family found in Thailand and neighboring countries (NCCIH). Its leaf contains many alkaloids, with mitragynine as the major one and 7-OH as a minor one. 7-OH is a single compound, so "7-OH" and "kratom" are not interchangeable terms.
Regulators draw the same line. FDA said its 2025 scheduling recommendation targets 7-OH as "a concentrated byproduct of the kratom plant" and "is not focused on natural kratom leaf products" (FDA). DEA's proposed ratio test uses the same idea: if mitragynine divided by 7-OH (or 7-OH plus MP) is less than 100, the material falls within the proposed Schedule I listing, because botanical leaf has far more mitragynine than 7-OH (FDA). A comparison of the two main alkaloids is on our mitragynine vs 7-OH page.
7-OH and related compounds
|
Compound |
What it is |
Federal status, 21 October 2026 |
|---|---|---|
|
Mitragynine |
The major alkaloid in kratom leaf |
DEA's fact sheet says kratom "is not a controlled substance" (DEA, October 2025); mitragynine is not covered by the proposed order (91 FR 65370) |
|
7-OH (7-hydroxymitragynine) |
Minor kratom alkaloid; also made from mitragynine |
Not yet scheduled; proposed for Schedule I above a threshold (91 FR 65370) |
|
MP (mitragynine pseudoindoxyl, also MGPI) |
"A chemical rearrangement product of 7-hydroxymitragynine," produced by synthetic modification |
Schedule I since 26 August 2026 at any amount; DEA intends to replace this with a threshold order (91 FR 54948) |
|
MGM-15 (dihydro-7-hydroxymitragynine) |
A synthetic derivative of 7-OH |
Schedule I since 26 August 2026 (91 FR 54948) |
|
MGM-16 (9-fluoro-dihydro-7-hydroxymitragynine) |
A synthetic derivative of 7-OH |
Schedule I since 26 August 2026 (91 FR 54948) |
DEA's August order says that, unlike mitragynine and 7-OH, which occur naturally in the plant, MP, MGM-15 and MGM-16 are synthetic derivatives (91 FR 54948). More detail is on our MGM-15 reference page.
How 7-OH compares with cannabis and kava
These three are often confused, but they come from unrelated plants and different chemical families.
- Kratom (source of 7-OH):Mitragyna speciosa, a tree in the coffee family; its active compounds are alkaloids (NCCIH).
- Cannabis:Cannabis sativa; its main active compounds are cannabinoids such as THC and CBD, not alkaloids (NCCIH). 7-OH is not a cannabinoid.
- Kava:Piper methysticum, a member of the pepper family native to the South Pacific (NCCIH). It is not related to kratom.
Federal status: what FDA and DEA say
FDA. "There are no FDA-approved 7-OH drugs, 7-OH is not lawful in dietary supplements and 7-OH cannot be lawfully added to conventional foods" (FDA, 29 July 2025). FDA has sent warning letters to seven companies, worked with the US Marshals on a seizure of about 73,000 units in Missouri in December 2025 (FDA), and lists a 7-OH product on its kratom import alert (Import Alert 54-15).
DEA. The 14 October 2026 notice would place 7-OH and MP in Schedule I when either alone, or both combined, is greater than 1 mg per gram (solids) or 1 mg per mL (liquids), or when the mitragynine ratio is below 100. The order takes effect on publication and lasts two years, with a possible one-year extension. DEA adds that "neither HHS nor DEA has made a finding that these substances are safe to use at below-threshold levels" (91 FR 65370). The full timeline is on our 7-OH federal status page.
State status
State law is separate from federal law, and the DEA notice says the federal action does not preempt stricter state rules. Citing a 2025 summary of state laws, the notice lists ten states that prohibit 7-OH (Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, Massachusetts, Tennessee, Vermont and Wisconsin), four that cap it (Arizona, Colorado, South Carolina and Texas), and 19 with a Kratom Consumer Protection Act (91 FR 65370). In California, a 9 January 2026 state health department letter says the sale and marketing of kratom and 7-OH products for consumption is unlawful (CDPH). State-by-state detail is on our 7-OH and kratom laws by state page.
Frequently asked questions
What is 7-OH?
7-OH is 7-hydroxymitragynine, an indole alkaloid found in small amounts in the kratom tree, Mitragyna speciosa (91 FR 65370). It differs from mitragynine by one hydroxyl group (PubChem). FDA describes it as an opioid.
Is 7-OH the same as kratom?
No. Kratom is a plant whose leaf contains many alkaloids, while 7-OH is one compound (NIDA). FDA treats concentrated 7-OH products as distinct from natural kratom leaf products (FDA).
Is 7-OH natural or synthetic?
It can be either. FDA says it occurs naturally in trace amounts in kratom, and DEA says it can also be made from mitragynine in a one-step reaction, with an identical structure either way (FDA; 91 FR 65370). DEA says commercial products contain far more 7-OH than botanical kratom.
Where does 7-OH come from?
Naturally, from kratom leaf, where it is a minor alkaloid and may form after harvest through oxidation (NIDA abstract). NIDA also says the body converts mitragynine into 7-OH (NIDA).
Is 7-OH legal?
Federally, 7-OH was not scheduled as of 21 October 2026, but DEA intends to place it in Schedule I above a threshold by an order that can publish on or after 13 November 2026 (91 FR 65370). FDA already says it is not lawful in foods or dietary supplements. Several states prohibit it outright.
Is 7-OH a cannabinoid?
No. 7-OH is an alkaloid from kratom, a tree in the coffee family, while cannabinoids such as THC and CBD come from the cannabis plant (NCCIH, kratom; NCCIH, cannabis). The two are chemically unrelated.
Sources
- Federal Register, 91 FR 65370: Temporary Placement of 7-Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I (14 October 2026) (checked 21 October 2026)
- Federal Register, 91 FR 54948: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I (26 August 2026) (checked 21 October 2026)
- FDA, FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers (29 July 2025) (checked 21 October 2026)
- FDA, FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine (15 July 2025) (checked 21 October 2026)
- FDA, FDA Seizes 7-OH Opioids to Protect American Consumers (2 December 2025) (checked 21 October 2026)
- FDA, Hiding in Plain Sight: 7-OH Products (content current as of 12 October 2026) (checked 21 October 2026)
- FDA, Import Alert 54-15 (published 17 August 2026) (checked 21 October 2026)
- DEA Diversion Control Division, Kratom (Mitragyna speciosa) drug and chemical fact sheet (October 2025) (checked 21 October 2026)
- PubChem, 7-Hydroxymitragynine (CID 44301524) (checked 21 October 2026)
- PubChem, Mitragynine (CID 3034396) (checked 21 October 2026)
- National Institute on Drug Abuse, Kratom research topic page (checked 21 October 2026)
- National Institute on Drug Abuse, abstract: Kratom consumed in Southeast Asia versus products consumed in the US (Karunakaran and Kasinather, 2024) (checked 21 October 2026)
- NCCIH, Kratom (checked 21 October 2026)
- NCCIH, Cannabis (Marijuana) and Cannabinoids: What You Need To Know (checked 21 October 2026)
- NCCIH, Kava (checked 21 October 2026)
- California Department of Public Health, letter on kratom and 7-OH products (9 January 2026) (checked 21 October 2026)